NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $20.38 -1.01 (-4.72%) Closing price 11/11/2026 04:00 PM EasternExtended Trading$20.24 -0.14 (-0.69%) As of 11/11/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Fortrea Stock (NASDAQ:FTRE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fortrea alerts:Sign Up Key Stats Today's Range$20.36▼$21.5850-Day Range$16.79▼$25.8852-Week Range$8.55▼$26.16Volume1.52 million shsAverage Volume2.17 million shsMarket Capitalization$1.97 billionP/E RatioN/ADividend YieldN/APrice Target$24.23Consensus RatingHold Company Overview Fortrea Holdings Inc. is a global contract research organization that provides clinical development and patient access services to pharmaceutical, biotechnology and medical device companies. The company supports the development of medicines and medical products from early research through later-stage clinical trials and post-approval studies. Its services include clinical trial planning and management, clinical pharmacology, patient recruitment and engagement, data management, regulatory support and related consulting. Fortrea also works with sponsors on clinical research across a range of therapeutic areas. Fortrea began operating as an independent company in 2023 after being spun off from Labcorp. Based in Durham, North Carolina, it serves clients and conducts research in countries around the world.AI Generated. May Contain Errors. Read More Fortrea Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreFTRE MarketRank™: 4.353103267285 of 5 starsFortrea scored higher than 87% of companies evaluated by MarketBeat, and ranked 123rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingHold Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 1 strong buy rating, 6 buy ratings, 3 hold ratings, and 3 sell ratings.Upside PotentialFortrea has a consensus price target of $24.23, representing about 18.9% upside from its current price of $20.38.Amount of Analyst CoverageFortrea has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth23.53% Earnings GrowthEarnings for Fortrea are expected to grow by 23.53% in the coming year, from $0.85 to $1.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -27.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -27.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 0.53. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 3.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.95% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 3.73, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fortrea has recently increased by 11.67%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. News and Social Media4.6 / 5News Sentiment1.40 News SentimentFortrea has a news sentiment score of 1.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Fortrea this week, compared to 4 articles on an average week.Search Interest2 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows4 people have added Fortrea to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,145.00 in company stock.Percentage Held by Insiders0.73% of the stock of Fortrea is held by insiders.Percentage Held by InstitutionsFortrea has minimal institutional ownership at this time.Read more about Fortrea's insider trading history. Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTRE Stock News HeadlinesFortrea Shares Fall After Mizuho Securities DowngradeNovember 11 at 8:00 PM | marketscreener.comMFortrea (NASDAQ:FTRE) Price Target Raised to $26.00November 2, 2026 | americanbankingnews.comMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending. | Porter & Company (Ad)Fortrea (NASDAQ:FTRE) Price Target Raised to $27.00November 2, 2026 | americanbankingnews.comFortrea Earnings Call Signals Recovery Despite Backlog ResetNovember 1, 2026 | tipranks.comFortrea (FTRE) Stock Drops After Q3 Results Lift GuidanceOctober 31, 2026 | finance.yahoo.comFortrea Holdings (FTRE) Stock Sees Modest Fair Value Lift As Margin Views ImproveOctober 31, 2026 | finance.yahoo.comFTRE Q3 deep dive: margin gains, backlog reset, and early-phase expansion shape outlookOctober 30, 2026 | msn.comSee More Headlines FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $17.25 on January 1st, 2026. Since then, FTRE stock has increased by 18.1% and is now trading at $20.38. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) posted its quarterly earnings results on Thursday, October, 29th. The company reported $0.28 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.06. The business earned $691.50 million during the quarter, compared to the consensus estimate of $671.57 million. Fortrea had a negative net margin of 2.58% and a positive trailing twelve-month return on equity of 13.98%. Read the conference call transcript. Who are Fortrea's major shareholders? Top institutional shareholders of Fortrea include Penn Capital Management Company LLC (1.18%), Public Sector Pension Investment Board (0.34%), Ieq Capital LLC (0.32%) and First Eagle Investment Management LLC (0.32%). Insiders that own company stock include Anshul Thakral, Thomas Pike, Peter M Neupert, Jill G Mcconnell, Robert Parks, James S Hanson, Erin L Russell and Carrie Elizabeth Russell. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fortrea own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fortrea investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Qualcomm (QCOM), Micron Technology (MU), ExxonMobil (XOM), Ares Capital (ARCC) and Costco Wholesale (COST). Company Calendar Last Earnings10/29/2026Today11/11/2026Jefferies Global Healthcare Conference11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 FTRE's financial health is in the Green zone, according to TradeSmith. FTRE has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:FTRE CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees14,300Year Founded2023Price Target and Rating Average Price Target for Fortrea$24.23 High Price Target$29.00 Low Price Target$19.00 Potential Upside/Downside+18.9%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($0.73) Trailing P/E RatioN/A Forward P/E Ratio19.41 P/E Growth0.53Net Income-$986.20 million Net Margins-2.58% Pretax Margin-1.98% Return on Equity13.98% Return on Assets2.76% Debt Debt-to-Equity Ratio1.94 Current Ratio0.97 Quick Ratio0.97 Sales & Book Value Annual Sales$2.72 billion Price / Sales0.72 Cash Flow$9.44 per share Price / Cash Flow2.16 Book Value$5.52 per share Price / Book3.69Miscellaneous Outstanding Shares96,500,000Free Float95,796,000Market Cap$1.97 billion OptionableOptionable Beta1.88 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:FTRE) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredThis 10.3% war bond closed once. It's finally open again.Todd Phillips has spent 30 years studying safe-money income. His test for real retirement income: can it promi...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
